A trio of scientists at the University of Wisconsin-Madison is launching a new research center to advance mass spectrometry-based proteomics in biomedical research, with the help of a grant from the National Institutes of Health and the National Institute of General Medical Sciences.
In efforts to understand what influences life span, cancer and aging, scientists are building road maps to navigate and learn about cells at the molecular level.
Josh Coon’s work has weight. It’s right there in the name: mass spectrometry. It’s there in the results, too, enabling science by giving researchers an ever-sharper understanding of the molecules that make up living things.
© 2020 Coon Research Group. - All Rights Reserved. | Privacy Policy